Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Medivir discloses RSV replication inhibitors

May 20, 2015

Janssen and Achillion establish global HCV collaboration

May 20, 2015

Bristol-Myers Squibb divulges inhibitors of HIV replication

May 20, 2015

DNA-YFVax shows promise as an alternative to expensive YFV vaccines

May 19, 2015

Taisho develops antibacterial hydroxamic acids

May 18, 2015

SYM-1219 enters phase III trial for bacterial vaginosis

May 15, 2015

Phase I trial initiated for Jiangsu Jindike Biotechnology influenza vaccine

May 15, 2015

TB Alliance initiates phase III trial of triple oral drug regimen in XDR-TB

May 15, 2015

Idenix disclose anti-HCV nucleotide prodrugs

May 15, 2015

Antabio receives funding to develop drugs for P. aeruginosa infection in CF patients

May 15, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...